| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Divisions of Neurology (Drs. Molloy, Needle, and Phillips, and S.N. Vaughan), Oncology (Drs. Molloy, Needle, and Phillips), Radiology (Dr. Bilaniuk), Neuro-Ophthalmology (Dr. Liu), and Genetics (Dr. Zackai), The Children's Hospital of Philadelphia, PA.
Received October 24, 1994. Accepted in final form March 6, 1995.
Address correspondence and reprint requests to Dr. Patricia T. Molloy, Division of Neurology, The Children's Hospital of Philadelphia, 324 South 34th Street, Philadelphia, PA 19104.
The natural history and the clinical and neuroimaging features of brainstem tumors in neurofibromatosis type 1 (NF1) are poorly understood.Magnetic resonance imaging (MRI) has been useful in NF1 in detecting intracranial abnormalities, especially of the brainstem. Brainstem tumors in NF1 have been confused clinically with non-NF1 brainstem tumors and radiographically with the increased T2 signal abnormalities, also known as "unidentified bright objects" (UBOs), which are common in NF1 and often located in the brainstem. This study, which evaluated 17 NF1 patients with brainstem tumors, is the largest series to date. Fifteen of 17 patients (88%) had neurologic signs and symptoms referable to brainstem dysfunction, including dysarthria, cranial neuropathies, and gross motor incoordination. Tumors were located primarily in the medulla in 14 of 17 NF1 patients (82%), in contrast to the pontine tumor location in the non-NF1 population. Seven NF1 patients (41%) required shunt placement for hydrocephalus at initial diagnosis, more frequent than in non-NF1 brainstem tumor patients. Six of 17 patients (35%) had evidence of radiographic tumor progression, but only three of them (18%) had correlative clinical progression. Two patients with progressive symptoms had partial surgical resection, and pathology revealed either fibrillary or anaplastic astrocytomas. Three patients were treated with radiation therapy, chemotherapy, or both, with two deaths. With a median follow-up of 52 months, 15 of 17 patients remain alive; 14 of them did not require adjuvant therapy. In our series, we describe NF1 brainstem tumors as a distinct clinical entity, much less aggressive than non-NF1 pontine tumors but more symptomatic than brainstem UBOs in NF1.
NEUROLOGY 1995;45: 1897-1902
This article has been cited by other articles:
|
|
 |
|
  J. Fangusaro Pediatric High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas J Child Neurol, November 1, 2009; 24(11): 1409 - 1417. [Abstract] [PDF]
|
|
|
|
 |
|
 J. R. Leonard, A. Perry, J. B. Rubin, A. A. King, M. R. Chicoine, and D. H. Gutmann The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1 Neurology, October 24, 2006; 67(8): 1509 - 1512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Theos and B. R. Korf Pathophysiology of neurofibromatosis type 1. Ann Intern Med, June 6, 2006; 144(11): 842 - 849. [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Grier and T. Batchelor Low-grade gliomas in adults. Oncologist, June 1, 2006; 11(6): 681 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Donaldson, F. Laningham, and P. G. Fisher Advances Toward an Understanding of Brainstem Gliomas J. Clin. Oncol., March 10, 2006; 24(8): 1266 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Broniscer and A. Gajjar Supratentorial High-Grade Astrocytoma and Diffuse Brainstem Glioma: Two Challenges for the Pediatric Oncologist Oncologist, April 1, 2004; 9(2): 197 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tada, M. Kochi, H. Saya, J.-i. Kuratsu, S. Shiraishi, T. Kamiryo, N. Shinojima, and Y. Ushio Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1 Neuro-oncol, October 1, 2003; 5(4): 228 - 234. [Abstract] [PDF]
|
|
|
|
|
|
D. H. Gutmann, S. A. Rasmussen, P. Wolkenstein, M. M. MacCollin, A. Guha, P. D. Inskip, K. N. North, M. Poyhonen, P. H. Birch, and J. M. Friedman Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1) Neurology, September 10, 2002; 59(5): 759 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Gutmann Review Article : Neurofibromin in the Brain J Child Neurol, August 1, 2002; 17(8): 592 - 601. [Abstract] [PDF]
|
|
|
|
|
|
T. Rosser and R. J. Packer Review Article : Intracranial Neoplasms in Children With Neurofibromatosis 1 J Child Neurol, August 1, 2002; 17(8): 630 - 637. [Abstract] [PDF]
|
|
|
|
|
|
S. Gururangan, C. M. Cavazos, D. Ashley, J. E. Herndon II, C. S. Bruggers, A. Moghrabi, D. L. Scarcella, M. Watral, S. Tourt-Uhlig, D. Reardon, et al. Phase II Study of Carboplatin in Children With Progressive Low-Grade Gliomas J. Clin. Oncol., July 1, 2002; 20(13): 2951 - 2958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-S. Guillamo, A. Creange, C. Kalifa, J. Grill, D. Rodriguez, F. Doz, S. Barbarot, M. Zerah, M. Sanson, S. Bastuji-Garin, et al. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): A retrospective study of 104 patients Brain, January 1, 2002; 126(1): 152 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Guillamo, A. Monjour, L. Taillandier, B. Devaux, P. Varlet, C. Haie-Meder, G.-L. Defer, P. Maison, J.-J. Mazeron, P. Cornu, et al. Brainstem gliomas in adults: prognostic factors and classification Brain, December 1, 2001; 124(12): 2528 - 2539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Korf Malignancy in Neurofibromatosis Type 1 Oncologist, December 1, 2000; 5(6): 477 - 485. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. J. DiMario Jr, G. R. Ramsby, and J. A. Burleson Brain Morphometric Analysis in Neurofibromatosis 1 Arch Neurol, November 1, 1999; 56(11): 1343 - 1346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Griffiths, F. PhD, S. Blaser, W. Mukonoweshuro, D. Armstrong, G. Milo-Manson, and S. Cheung Neurofibromatosis Bright Objects in Children With Neurofibromatosis Type 1: A Proliferative Potential? Pediatrics, October 1, 1999; 104(4): 49e - 49. [Abstract] [Full Text]
|
|
|
|
 |
|
 O. Gonen, Z. J. Wang, A. K. Viswanathan, P. T. Molloy, and R. A. Zimmerman Three-Dimensional Multivoxel Proton MR Spectroscopy of the Brain in Children with Neurofibromatosis Type 1 AJNR Am. J. Neuroradiol., August 1, 1999; 20(7): 1333 - 1341. [Abstract] [Full Text]
|
|
|
|
|
|
F. J. DiMario Jr and G. Ramsby Magnetic Resonance Imaging Lesion Analysis in Neurofibromatosis Type 1 Arch Neurol, April 1, 1998; 55(4): 500 - 505. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
